89 related articles for article (PubMed ID: 10839290)
1. Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer.
Propper DJ; Levitt NC; O'Byrne K; Braybrooke JP; Talbot DC; Ganesan TS; Thompson CH; Rajagopalan B; Littlewood TJ; Dixon RM; Harris AL
Br J Cancer; 2000 Jun; 82(11):1776-82. PubMed ID: 10839290
[TBL] [Abstract][Full Text] [Related]
2. A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopy.
Philip PA; Thompson CH; Carmichael J; Rea D; Mitchell K; Taylor DJ; Stuart NS; Dennis I; Rajagopalan B; Ganesan T
Cancer Res; 1993 Dec; 53(23):5649-53. PubMed ID: 8242619
[TBL] [Abstract][Full Text] [Related]
3. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M
Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990
[TBL] [Abstract][Full Text] [Related]
4. Hepatic intra-arterial chemotherapy using a percutaneous catheter in pretreated patients with metastatic colorectal carcinoma.
Fazio N; Orsi F; Grasso RF; Ferretti G; Medici M; Rocca A; Zampino G; Curigliano G; De Pas T; Colleoni M; Bonomo G; Marrocco E; Lunghi L; De Braud F
Anticancer Res; 2003; 23(6D):5023-30. PubMed ID: 14981962
[TBL] [Abstract][Full Text] [Related]
5. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
Sobrero A; Guglielmi A; Cirillo M; Recaldin E; Frassineti GL; Aschele C; Ravaioli A; Testore P; Caroti C; Gallo L; Pessi MA; Cortesi E; Turci D; Grossi F; Labianca R
Br J Cancer; 2001 Apr; 84(8):1023-8. PubMed ID: 11308248
[TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
[TBL] [Abstract][Full Text] [Related]
7. [Hepatic arterial infusion of IL-2 and chemotherapy for unresectable liver metastasis from colorectal cancer].
Yoshimura K; Hazama S; Iizuka N; Takano N; Matsuoka K; Tangoku A; Oka M
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2117-20. PubMed ID: 12484016
[TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.
Chau I; Webb A; Cunningham D; Hill M; Waters JS; Norman A; Massey A
Br J Cancer; 2001 Nov; 85(9):1258-64. PubMed ID: 11720458
[TBL] [Abstract][Full Text] [Related]
10. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group].
Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A;
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer.
Ramsay JR; Bleehen NM; Dennis I; Workman P; Ward R; Falk SJ; Bedford P; Wootton R; Nethersell AB
Int J Radiat Oncol Biol Phys; 1992; 22(4):721-5. PubMed ID: 1544845
[TBL] [Abstract][Full Text] [Related]
12. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
Link K; Happich K; Schirner I; Jüngert B; Brückl V; Männlein G; Brückl WM; Merkel S; Göhl J; Hohenberger W; Hahn EG; Wein A
Anticancer Res; 2004; 24(1):385-91. PubMed ID: 15015625
[TBL] [Abstract][Full Text] [Related]
13. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A
J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495
[TBL] [Abstract][Full Text] [Related]
14. [Results of hepatic arterial infusion chemotherapy with 5-FU and leucovorin for unresectable liver metastases from colorectal cancer].
Yamashita K; Urakami A; Kubota H; Nagatsuka R; Murakami H; Kawabe Y; Higashida M; Hirabayashi Y; Mikami Y; Ikeda M; Fuchimoto M; Yamamura M; Oka Y; Okumura H; Iki K; Matsumoto H; Imai S; Hirai T; Tsunoda T
Gan To Kagaku Ryoho; 2008 Jan; 35(1):71-6. PubMed ID: 18195531
[TBL] [Abstract][Full Text] [Related]
15. Repeated hepatic intra-arterial chemotherapy based on results of anticancer drug sensitivity test in patients with synchronous hepatic metastases from colorectal cancer.
Matsuoka H; Nagaya M; Tsukikawa S; Yanagi Y; Isogai A; Kubota S
Surgery; 2006 Sep; 140(3):387-95. PubMed ID: 16934600
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer.
Chiara S; Nobile MT; Gozza A; Taveggia P; Heouaine A; Pastrone I; Percivale PL; Lionetto R; Sanguineti O; Rosso R
Anticancer Res; 2004; 24(1):355-60. PubMed ID: 15015621
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study.
Fiorentini G; Rossi S; Dentico P; Meucci F; Bonechi F; Bernardeschi P; Cantore M; Guadagni S; De Simone M
Anticancer Res; 2004; 24(3b):2093-6. PubMed ID: 15274406
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of BW12C and mitomycin C, given in combination in a phase 1 study in patients with advanced gastrointestinal cancer.
Dennis IF; Ramsay JR; Workman P; Bleehen NM
Cancer Chemother Pharmacol; 1993; 32(1):67-72. PubMed ID: 8462126
[TBL] [Abstract][Full Text] [Related]
19. [A case report of complete remission of liver metastases from colorectal cancer treated with continuous hepatic arterial infusion].
Tokunaga T; Sumimura J; Yoshidome K; Fujita S; Tsuji K; Oota F; Tsuboyama N; Nagai I
Gan To Kagaku Ryoho; 2003 Jul; 30(7):1009-11. PubMed ID: 12894720
[TBL] [Abstract][Full Text] [Related]
20. BW12C: effects on tumour hypoxia, tumour thermosensitivity and relative tumour and normal tissue perfusion in C3H mice.
Honess DJ; Hu DE; Bleehen NM
Br J Cancer; 1991 Oct; 64(4):715-22. PubMed ID: 1911220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
